NSE filing, NSE: AFFLE. Summary written from the filing by ALFA Finder's alert engine.
Affle 3I Ltd: key numbers
- Share price
- ₹1,411.00
- Market cap
- ₹20,304 Cr
- Revenue (annual)
- ₹2,709 Cr
- Net profit (annual)
- ₹454.9 Cr
- P/E (TTM)
- 42.5×Sector 22.9×
- Promoter holding
- 55.42%+0.51% QoQ
- FII holding
- 14.36%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Affle 3I Ltd
All →Affle 3I Board Meeting Date
Affle 3i will hold a board meeting on 30 October 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 2026. This is a prior intimation, so the results are not yet approved.
Affle 3I Other Announcement
Affle 3i Ltd filed its quarterly shareholding pattern as of 19 October 2026. The filing reflects warrant-conversion share allotments to Affle Holdings.
Affle 3I Preferential Issue
Affle 3i converted 12,77,155 warrants into equity shares at ₹1,487 per share. The allotment raises approximately ₹189.91 Crore from a single investor.
- Value
- ₹189.9 Cr
Affle 3I Convertible Warrants
Affle 3i converted 17,04,324 warrants into equity shares at ₹836.44 per share. The allotment raised ₹14.26 Crore from one investor.
- Value
- ₹14.26 Cr
Affle 3I Convertible Warrants
Affle 3I allotted 17,04,324 shares to promoter Affle Holdings on warrant conversion at ₹1,115.25 each. The deal adds ~₹190 Crore to paid-up capital.
- Value
- ₹190.1 Cr
Affle 3I Insolvency Petition
Affle 3i Limited announced that the Hon’ble Supreme Court has granted a stay on the CIRP proceedings pending before the NCLT regarding its investment in Bobble.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date